REFERENCES
Wissel PS, Sordillo P, Anderson KE, Sassa S, Savillo RL, Kappas A: Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Hematol 25:107–113, 1987
McAlister F, McClean K, Hamilton PG, Houston S: Human immunodeficiency virus infection and porphyria cutanea tarda: Coexistance of risk factors or causative association? Clin Infect Dis 20:348–351, 1995
Nomura N, Zolla-Pazner S, Simberkoff M, Kim M, Sassa A, Lim HW: Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection. Arch Dermatol 32:906–910, 1996
O'Connor W, Murphy GM, Darby C, Fogarty J, Mulcahy F, O'Moore R, Barnes L: Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol 132:1443–1447, 1996
Cribier B, Rey D, Uhl G, Le Coz C, Hirth C, Libbrecht E, Vetter D, Lang JM, Stoll-Keller F, Grosshans E: Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients. Arch Dermatol 132:1448–1452, 1996
Elder GH: Porphyria cutanea tarda. Semin Liver Dis 18:67–75, 1998
Reynaud P, Goodfellow K, Svec F: Porphyria cutanea tarda as initial presentation of the acquired immunodeficiency syndrome in two patients. J Infect Dis 161:1032–1033, 1990 ( letter)
Blauvelt A: Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda. Arch Dermatol 132:1503–1504, 1996 (editorial)
Siegel LB, Eber BB: Porphyria cutanea tarda remission. Ann Intern Med 121:308–309, 1994 ( letter)
Sheikh MY, Wright RA, Burruss JB: Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C. Dig Dis Sci 43:529–533, 1998
Herranz MT, El Amrani A, Aranegui P, Jimenez-Alonso JF, Rodenas JM, Vivaldi RM: Porphyria cutanea tarda and acquired immunodeficiency syndrome: Pathogenetic implications. Arch Dermatol 127:1585–1586, 1991 ( letter)
Castanet J, Lacour JP, Bodokh J, Bekri S, Ortonne JP: Porphyria cutanea tarda in association with human immunodeficiency virus infection: Is it related to hepatitis C virus infection? Arch Dermatol 130:664–665, 1994
Rutschmann OT, Hirschel B, Negro F, Perrin LH: Lack of effect of long-term HAART on hepatitis C (HCV) viremia. In Conference record of the 12th World AIDS Conference. Geneva, Marathon Multimedia, 1998, pp 309–310 (abstract no 22238)
Blauvelt A, Harris HR, Hogan DJ, Jimenez-Acosta F, Ponce I, Pardo RJ: Porphyria cutanea tarda and human immunodeficiency virus infection. Int J Dermatol 31:474–479, 1992
Rights and permissions
About this article
Cite this article
Rich, J.D., Mylonakis, E., Nossa, R. et al. Case Report: Highly Active Antiretroviral Therapy Leading to Resolution of Porphyria Cutanea Tarda in a Patient with AIDS and Hepatitis C. Dig Dis Sci 44, 1034–1037 (1999). https://doi.org/10.1023/A:1026681218915
Issue Date:
DOI: https://doi.org/10.1023/A:1026681218915